 |
市場調查報告書
商品編碼
1747285
血球因子市場：依產品類型、依來源、依應用、依給藥途徑、依最終使用者、按地區Blood Cell Factors Market, By Product Type, By Source, By Application, By Route of Administration, By End user, By Geography |
||||||
價格
簡介目錄
預計 2025 年全球血球因子市場規模為 33.7 億美元，到 2032 年將達到 43.1 億美元，2025 年至 2032 年的複合年成長率為 3.6%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年的市場規模 | 33.7億美元 |
| 效能數據 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期：2025-2032年複合年成長率： | 3.60% | 2032年價值預測 | 43.1億美元 |
全球血球因子市場已成為醫療保健產業的重要組成部分，在各種血液疾病的治療和管理中發揮關鍵作用。血球因子是調節血球因子（包括紅血球、白血球和血小板）生長、分化和功能所必需的蛋白質和分子。近年來，這些因子因其有助於治療各種血液相關疾病（包括貧血、血小板減少性疾病和血小板減少症）的潛力而引起了廣泛關注。血球因子市場的發展受到血液疾病盛行率不斷上升、生物技術和藥物研究的進步以及對有效和有針對性的治療需求不斷成長的驅動。本文旨在全面概況全球血球因子市場，強調其現狀、關鍵促進因素和挑戰以及未來前景。
市場動態：
全球血球因子市場受到多種關鍵促進因素、市場限制因素和機會的影響。其中一個關鍵促進因素是全球貧血、白血病和淋巴瘤等血液疾病發生率的上升。這些疾病的日益普及使得對血球因子相關有效治療的需求龐大。此外，日益成長的老齡化人口更容易患上血液相關疾病，這進一步推動了市場的成長。生物技術和藥物研究的進步也促進了新型標靶治療的開發，並在推動市場發展方面發揮關鍵作用。然而，也存在一些市場限制因素，例如高昂的研發成本、嚴格的監管要求以及血球因子療法可能產生的副作用。這些挑戰可能會阻礙這些療法的廣泛採用和可及性。儘管存在這些市場限制因素，但該市場仍提供了巨大的成長和創新機會。對個人化醫療的日益關注、生物相似藥的市場開發以及新興經濟體醫療基礎設施的不斷擴大，預計將為市場相關人員開闢新的途徑。此外，製藥公司、研發機構和政府機構之間的合作預計將加速血球因子療法的市場開發和商業化，預計這將推動未來的市場成長。
本研究的主要特點
- 本報告對全球血球因子市場進行了詳細分析，並展示了預測期（2025-2032 年）的市場規模（以十億美元為單位）和年複合成長率（CAGR%），以 2024 年為基準年。
- 它還強調了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
- 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
- 全球血球因子市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
- 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
- 全球血球因子市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
- 透過分析全球血球因子市場所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。
目錄
第1章 研究目的與前提
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要進展
- 監管情景
- 產品發布/核准
- PEST分析
- 波特分析
- 併購場景
- 產業趨勢
4. 2020 年至 2032 年全球血球因子市場（依產品類型）
- 促紅血球生成素促效劑 (ESA)
- 顆粒細胞增生因子（G-CSF）
- 粒細胞-巨噬細胞集落刺激因子（GM-CSF）
- 血小板生成素受體促效劑
- 幹細胞因子
- 其他血球因子（例如白細胞介素）
5. 全球血球因子市場（依來源分類），2020 年至 2032 年
- 重組（源自rDNA技術）
- 天然（血漿衍生）
6. 全球血球因子市場（依應用分類），2020-2032
- 腫瘤學
- 腎臟病學
- 血液系統疾病
- 感染疾病
- 自體免疫疾病
- 其他（例如，HIV相關貧血）
7. 全球血球激素市場（依給藥途徑分類），2020 年至 2032 年
- 注射
- 口服
8. 全球血球因子市場（依最終用戶分類），2020 年至 2032 年
- 醫院
- 門診手術中心
- 家庭醫療保健
- 專科診所
- 研究和學術機構
- 其他
9. 2020 年至 2032 年按地區分類的全球血球因子市場
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 南非
- 北非
- 中部非洲
第10章 競爭格局
- Amgen Inc.
- Johnson & Johnson
- Roche Holding AG
- Novartis AG
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Gilead Sciences, Inc.
- Sanofi SA
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Celgene Corporation
- Takeda Pharmaceutical Company Limited
- Regeneron Pharmaceuticals, Inc.
第 11 章分析師建議
- 命運之輪
- 分析師觀點
- Coherent Opportunity Map
第12章參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI7942
Global Blood Cell Factors Market is estimated to be valued at USD 3.37 Bn in 2025 and is expected to reach USD 4.31 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3.37 Bn |
| Historical Data for: | 2020 to 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 3.60% | 2032 Value Projection: | USD 4.31 Bn |
The global blood cell factors market has emerged as a critical component of the healthcare industry, playing a vital role in the treatment and management of various hematological disorders. Blood cell factors are essential proteins and molecules that regulate the growth, differentiation, and function of blood cells, including red blood cells, white blood cells, and platelets. These factors have gained significant attention in recent years due to their potential in treating a wide range of blood-related diseases, such as anemia, leukemia, and thrombocytopenia. The market for blood cell factors is driven by the increasing prevalence of hematological disorders, advancements in biotechnology and pharmaceutical research, and the growing demand for effective and targeted therapies. This article aims to provide a comprehensive overview of the global blood cell factors market, highlighting its current state, key drivers, challenges, and future prospects.
Market Dynamics:
The global blood cell factors market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the rising incidence of hematological disorders worldwide, such as anemia, leukemia, and lymphoma. The increasing prevalence of these diseases has created a significant demand for effective treatments, including blood cell factors. Additionally, the growing aging population, which is more susceptible to blood-related disorders, has further fueled the market growth. Advancements in biotechnology and pharmaceutical research have also played a crucial role in driving the market, enabling the development of novel and targeted therapies. However, the market also faces certain restraints, such as the high cost of research and development, stringent regulatory requirements, and the potential side effects associated with blood cell factor therapies. These challenges can hinder the adoption and accessibility of these treatments. Despite these restraints, the market presents significant opportunities for growth and innovation. The increasing focus on personalized medicine, the development of biosimilars, and the expansion of healthcare infrastructure in emerging economies are expected to create new avenues for market players. Moreover, collaborations between pharmaceutical companies, research institutions, and government organizations are likely to accelerate the development and commercialization of blood cell factor therapies, thereby driving market growth in the coming years.
Key features of the study:
- This report provides in-depth analysis of the global blood cell factors market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global blood cell factors market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Amgen Inc., Johnson & Johnson, Roche Holding AG, Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Inc., Sanofi S.A., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Celgene Corporation, Takeda Pharmaceutical Company Limited, and Regeneron Pharmaceuticals, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global blood cell factors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood cell factors market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Erythropoietin Stimulating Agents (ESAs)
- Granulocyte Colony-Stimulating Factor (G-CSF)
- Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
- Thrombopoietin Receptor Agonists
- Stem Cell Factor
- Other Blood Cell Factors (e.g. Interleukins)
- Source Insights (Revenue, USD Bn, 2020 - 2032)
- Recombinant (rDNA technology-derived)
- Natural (Plasma-derived)
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Nephrology
- Hematology Disorders
- Infectious Diseases
- Autoimmune Disorders
- Others (e.g., HIV-related anemia)
- Route Of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Injectable
- Oral
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Ambulatory Surgical Centers
- Home Healthcare
- Specialty Clinics
- Research & Academic Institutes
- Others
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Amgen Inc.
- Johnson & Johnson
- Roche Holding AG
- Novartis AG
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Gilead Sciences, Inc.
- Sanofi S.A.
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Celgene Corporation
- Takeda Pharmaceutical Company Limited
- Regeneron Pharmaceuticals, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Blood Cell Factors Market, By Product Type
- Global Blood Cell Factors Market, By Source
- Global Blood Cell Factors Market, By Application
- Global Blood Cell Factors Market, By Route of Administration
- Global Blood Cell Factors Market, By End user
- Global Blood Cell Factors Market, By Region
3. Market Dynamics, Regulations, And Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Blood Cell Factors Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Erythropoietin Stimulating Agents (ESAs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Granulocyte Colony-Stimulating Factor (G-CSF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Thrombopoietin Receptor Agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Stem Cell Factor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other Blood Cell Factors (e.g. Interleukins)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Blood Cell Factors Market, By Source, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Recombinant (rDNA technology-derived)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Natural (Plasma-derived)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Blood Cell Factors Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nephrology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hematology Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Autoimmune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (e.g., HIV-related anemia)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Blood Cell Factors Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Blood Cell Factors Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Home Healthcare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research & Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Blood Cell Factors Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gilead Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Celgene Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Regeneron Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
02-2729-4219
+886-2-2729-4219
